Hoth Therapeutics Stock Volatility
| HOTH Stock | USD 0.81 0.01 1.25% |
Sharpe Ratio = -0.018
| Leading Returns | Top Quartile | |||
| Strong | ||||
| Moderate | ||||
| Modest | ||||
| Cash | Low | Moderate | Elevated | High |
| Below Benchmark | HOTH |
Latest disclosures for Hoth Therapeutics show a Market Risk Adjusted Performance of -0.1%, a Risk of 7.06, and a Risk Adjusted Performance of -0.01%. Based on monthly moving averages, the stock is not performing at its full potential.
Key indicators related to Hoth Therapeutics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Key risk metrics for Hoth Therapeutics (3 Months):
Beta 1.4 | Alpha -0.15 | Risk 7.06 | Sharpe Ratio -0.02 | Expected Return -0.13 |
Moving together with Hoth Stock
Moving Against Hoth Stock
| 0.54 | OEC | Orion Engineered Carbons | PairCorr |
| 0.41 | PFE | Pfizer Inc | PairCorr |
| 0.36 | EPD | Enterprise Products Earnings Call This Week | PairCorr |
| 0.33 | UAN | CVR Partners LP | PairCorr |
| 0.32 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.31 | CSBI | Carroll Shelby | PairCorr |
Sensitivity To Market
Beta analysis for Hoth Therapeutics evaluates how its price movements correlate with the broader market. With a beta of 1.4, Hoth Therapeutics reflects measurable exposure to systematic risk. Observed total volatility stands near 7.06%. Asymmetric risk in Hoth Therapeutics is visible through downside-focused metrics. Downside deviation reads 0.0% and semi-deviation reads 0.0%, isolating the loss-side component of total return variability. Equity volatility compresses in calm markets and expands quickly when uncertainty increases. Stock dispersion changes materially during earnings seasons and macro data releases.
3 Months Beta |Hoth Therapeutics Demand TrendCurrent 90-day Hoth Therapeutics correlation with market (Dow Jones Industrial)Downside Risk
The standard deviation reading for Hoth summarizes how concentrated or dispersed daily returns have been around their mean. Volatile instruments have higher standard deviations; stable ones have lower. Comparing Hoth standard deviation against sector peers reveals whether its volatility is typical or an outlier.
Standard Deviation | 7.06 |
Total price dispersion in Hoth Therapeutics captures both upside and downside movement. While standard deviation captures total volatility, downside deviation focuses exclusively on the loss side of Hoth Therapeutics' returns. A complete risk picture of Hoth Therapeutics emerges when standard deviation and downside deviation are examined together. Latest disclosures for Hoth Therapeutics show a Maximum Drawdown of 48.52.
Stock Volatility Analysis
Hoth Therapeutics stock volatility is a measure of the speed and extent of Hoth Therapeutics' price movements. A higher-volatility stock like Hoth Therapeutics may generate large gains or losses in a short timeframe. In most cases, the higher the volatility, the riskier the stock.
Transformation |
This analysis covers sixty-one data points across the selected time horizon. The Average Price transformation calculates the mean of Hoth Therapeutics's open, high, low, and close for each trading period. By incorporating all four price components equally, it provides a balanced representation of each period's trading activity. Compared to using the closing price alone, the average price reduces the influence of end-of-day positioning and can serve as a smoother input for other technical indicators.
Projected Return Density Against Market
Given a 90-day horizon, Hoth Therapeutics has a beta of 1.3999. This usually indicates when the benchmark rises, the company tends to outperform it on average. However, when benchmark returns turn negative, Hoth Therapeutics tends to underperform.Systematic exposure aligns Hoth Therapeutics with broad stock market volatility, while unsystematic drivers reflect company or sector-specific developments. Latest disclosures for Hoth Therapeutics show a Mean Deviation of 4.21 and a Standard Deviation of 6.95.
Predicted Return Distribution |
| Density |
What Drives Hoth Therapeutics' Price Volatility?
Industry Dynamics
Peer results and sector re-ratings in the Pharmaceuticals sector often influence how investors price Hoth Therapeutics' risk.Political and Economic Environment
Macro data and central-bank signals can change valuation assumptions and short-term positioning around Hoth Therapeutics.Hoth Therapeutics' Company-Specific Factors
Company-specific events such as product updates, strategic actions, or execution issues can trigger volatility clusters.Stock Risk Measures
Given a 90-day horizon, the coefficient of variation of Hoth Therapeutics is -5542.61. The daily returns are distributed with a variance of 49.79 and standard deviation of 7.06. The mean deviation of Hoth Therapeutics is currently at 4.3. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.94
α | Alpha over Dow Jones | -0.1463 | |
β | Beta against Dow Jones | 1.40 | |
σ | Overall volatility | 7.06 | |
Ir | Information ratio | -0.0211 |
Stock Return Volatility
Daily return volatility for Hoth Therapeutics measures how far stock returns deviate from their average on a day-to-day basis. The firm shows 7.0564% volatility of returns over 90 trading days. For comparison, Dow Jones Industrial reported 0.9502% volatility on return distribution over a 90-day investment horizon. Performance |
| Timeline |
Related Correlations Analysis
Please upgrade your account to get full access to Macroaxis premium features
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Evaluating Hoth Stock requires separating price momentum from underlying operating strength versus competitors. Risk-adjusted metrics help compare Hoth Therapeutics' efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CRIS | 4.34 | -0.44 | 0.00 | -0.27 | 0.00 | 9.20 | 37.24 | |||
| BCTX | 3.31 | -0.04 | 0.00 | -0.04 | 0.00 | 6.27 | 23.17 | |||
| PALI | 4.27 | 0.41 | 0.07 | 0.33 | 5.22 | 10.34 | 30.02 | |||
| PCSA | 4.80 | 0.14 | 0.02 | 0.11 | 6.87 | 10.24 | 37.67 | |||
| ASBP | 9.12 | -2.15 | 0.00 | -0.53 | 0.00 | 13.33 | 100.51 | |||
| LEXX | 3.92 | 0.37 | 0.08 | 0.33 | 4.04 | 10.61 | 26.14 | |||
| FBLG | 6.05 | -1.69 | 0.00 | 1.09 | 0.00 | 11.58 | 69.81 | |||
| PULM | 4.40 | -0.70 | 0.00 | -1.93 | 0.00 | 8.78 | 46.65 | |||
| DARE | 3.73 | 0.37 | 0.08 | 0.36 | 4.07 | 7.86 | 69.73 | |||
| ENTO | 7.46 | -0.08 | 0.00 | 0.08 | 0.00 | 16.86 | 39.61 |
Risk Metrics, Assumptions & Methodology
Beta for Hoth Therapeutics measures the share of volatility attributable to broad market movements versus company-specific factors. Systematic risk dominates during market stress, often overwhelming any diversification benefit from low average beta. Hoth Therapeutics has a market cap of 15.49 M, ROE of -1.91%.
Hoth Therapeutics values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Volatility and downside metrics are estimated from historical return dispersion.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board
Hoth Therapeutics Volatility Profile Summary
Recent data suggests that Hoth Therapeutics is more volatile than Dow Jones Industrial by approximately 7.43x over the selected horizon. This differential reflects the relative dispersion of returns and frames how the asset responds to broader market conditions. Observed price behavior indicates modest directional movement within the current volatility regime. Across the current 90-day horizon, that places the security below 63% of the broader equity and portfolio universe on a pure volatility basis. This positioning reflects relative dispersion compared to peers rather than extreme instability.Hoth Therapeutics with characteristics aligned to broad market upside participation. This move summary looks at how the current session may translate into a basic near-term setup. It highlights whether the move looks ordinary, stressed, or unusually speculative for the instrument. a large bullish trend. Return distributions derived from historical modeling outline a range of potential outcomes over the selected 90-day horizon. View Hoth Therapeutics probability analysis.
Good diversification
The correlation between Hoth Therapeutics and Dow Jones is 0.19, which Macroaxis classifies as Good diversification for the selected horizon. Lower overlap tends to improve diversification, while higher overlap means both positions carry similar risk.
Hoth Therapeutics Additional Risk Indicators
Secondary risk indicators for Hoth Therapeutics evaluate exposure beyond standard deviation, beta, or one headline volatility measure. These measures support both standalone risk assessment and portfolio-level analysis.
| Risk Adjusted Performance | -0.01 | |||
| Market Risk Adjusted Performance | -0.1 | |||
| Mean Deviation | 4.21 | |||
| Coefficient Of Variation | -5,052 | |||
| Standard Deviation | 6.95 | |||
| Variance | 48.33 | |||
| Information Ratio | -0.02 |
Hoth Therapeutics Suggested Diversification Pairs
A pair-trading setup around Hoth Therapeutics shifts the return benchmark from the broad market to a second position, altering the risk profile. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Pair diversification lowers aggregate risk, though certain risk categories remain unaffected regardless of how positions are paired. Systematic risk - the risk tied to the broad market - cannot be eliminated by pairing Hoth Therapeutics with another position. However, Hoth Therapeutics' company-specific risk can be partially offset by selecting a pair that does not move in lockstep with Hoth Therapeutics.
Popular Tools for Hoth Stock analysis
Insider ScreenerFind insiders across different sectors to evaluate their impact on performanceOptions AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfoliosPortfolio AnywhereTrack or share privately all of your investments from the convenience of any deviceUSA ETFsFind actively traded Exchange Traded Funds (ETF) in USA